Regeneron Says FDA Rejects BLA Approval For Odronextamab In Follicular Lyphoma
Regeneron Pharmaceuticals, Inc.
Read moreRegeneron Pharmaceuticals, Inc.
Read moreBitfarms Ltd.
Read moreUnited Therapeutics Corp.
Read moreThe latest data from the Chicago Fed National Acti
Read moreThe bias remains bullish despite the current sell-
Read moreGlobal Business Travel Group, Inc.
Read moreIngersoll Rand Inc.
Read moreAxsome Therapeutics, Inc.
Read moreCleveland-Cliffs Inc.
Read moreThe latest data on building permits in the United
Read more